This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alleghany Buys Transatlantic, Ends Bidding War

Updated from 7:53 a.m. EST, and with analyst comment.

NEW YORK ( TheStreet) -- Transatlantic Holdings (TRH) on Monday announced an agreement to be acquired by Alleghany (Y - Get Report) for $3.4 billion.

The New York reinsurer's agreement to sell to Alleghany for $59.79 cents a share in cash and stock wards off a rival hostile bid by Validus (VR - Get Report), which on Nov. 8 mailed a letter to Transatlantic's shareholders, increasing its offer to $57.67 a share.

On Nov 10, Transatlantic CEO Robert Orlich said in a letter to shareholders that Validus' offer undervalued the company.

The Insurance Insider reported on Friday that an investor group headed by Stone Point Capital and including J.C. Flowers & Co. had made an all-cash offer for Transatlantic, valued at "more than $60 a share."

The Alleghany deal represents only a 10% premium from Transatlantic's closing price of $54.43, but the target company said that Alleghany's bid was "a 36% premium to Transatlantic's closing stock price on June 10, 2011, the last trading day before public announcement of the since-terminated merger agreement with Allied World Assurance (AWH)."

Transatlantic said it expected the sale to Alleghany to be "tax free to Transatlantic stockholders," who would receive "per-share consideration consisting of 0.145 Alleghany common shares and $14.22 in cash," with an option "to receive cash or stock consideration, subject to proration in the event of oversubscription."

Transatlantic in August received an unsolicited acquisition bid from National Indemnity -- a subsidiary of Warren Buffett's Berkshire Hathaway (BRK.B - Get Report) -- for $52 a share.

Transatlantic said following the completion of the transaction that it would "become an independent stand-alone subsidiary of Alleghany," and expected that it would "maintain its current financial strength ratings of 'A+' from Standard & Poor's and 'A' from A.M. Best."

Following the departure of outgoing Transatlantic CEO Robert Orlich at the end of the year, Transatlantic President Michael Sapnar will take on the additional role of CEO.

Gavin Magor, a senior analyst with Weiss Ratings, said "Transatlantic is lucky to be attracting bids, because of their excessive claims. The price being paid -- of roughly 85% book value -- is fair, but with Alleghany having one of the highest price-to-earnings ratios among insurers, Transatlantic's shareholders might have preferred to see an all-cash deal."

-- Written by Philip van Doorn in Jupiter, Fla.

To contact the writer, click here: Philip van Doorn.

To follow the writer on Twitter, go to
Philip W. van Doorn is a member of TheStreet's banking and finance team, commenting on industry and regulatory trends. He previously served as the senior analyst for Ratings, responsible for assigning financial strength ratings to banks and savings and loan institutions. Mr. van Doorn previously served as a loan operations officer at Riverside National Bank in Fort Pierce, Fla., and as a credit analyst at the Federal Home Loan Bank of New York, where he monitored banks in New York, New Jersey and Puerto Rico. Mr. van Doorn has additional experience in the mutual fund and computer software industries. He holds a bachelor of science in business administration from Long Island University.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BRK.A $197,341.00 -0.61%
BRK.B $131.25 -0.85%
Y $476.08 0.29%
VR $43.67 -2.70%
AAPL $111.35 0.51%


Chart of I:DJI
DOW 16,810.20 +33.77 0.20%
S&P 500 1,979.18 -7.87 -0.40%
NASDAQ 4,742.7060 -38.5580 -0.81%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs